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Abstract
Deep-coverage metabolomic profiling has revealed a well-defined development of meta-
bolic decay in human red blood cells (RBCs) under cold storage conditions. A set of extra-
cellular biomarkers has been recently identified that reliably defines the qualitative state of
the metabolic network throughout this metabolic decay process. Here, we extend the utility
of these biomarkers by using them to quantitatively predict the concentrations of other
metabolites in the red blood cell. We are able to accurately predict the concentration profile
of 84 of the 91 (92%) measured metabolites (p < 0.05) in RBC metabolism using only mea-
surements of these five biomarkers. The median of prediction errors (symmetric mean abso-
lute percent error) across all metabolites was 13%. The ability to predict numerous
metabolite concentrations from a simple set of biomarkers offers the potential for the devel-
opment of a powerful workflow that could be used to evaluate the metabolic state of a biolog-
ical system using a minimal set of measurements.
Author summary
While deep-coverage omics data sets are allowing for more complete characterization of
biological systems, there has been a concerted effort to identify a subset of measurements
that are representative of qualitative network-level behavior. For some systems—like the
human red blood cell (RBC)—such biomarkers have already been identified. Using the
concentration profiles of these biomarkers as input to a statistical model, we predict quan-
titative concentration profiles of other metabolites in the RBC network. These results
demonstrate that if good biomarkers are available for a biological system, it is possible to
use these measurements to gain insight into the quantitative state of the rest of the
network.
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Introduction
The data generated from deep coverage omics tools are becoming broadly available and thus
their use is becoming more common [1, 2]. With this data, researchers have begun to identify
metabolomics biomarkers that can be used to describe systemic behavior with only a few
inexpensive and reliable measurements [3–7]. In transfusion medicine, deep coverage meta-
bolomics data sets for human red blood cells (RBCs) in cold storage are rapidly accumulating
[8] and have been used to characterize the state of the RBC metabolic network during storage
[9–13].
Big data analysis of RBC metabolomics data has yielded a well-defined three-phase pattern
of metabolic storage lesion that has fundamental consequences for blood storage [10, 13].
Recently, eight extracellular metabolic biomarkers have been identified that reliably define this
three-phase decay process observed in RBCs [6]. These biomarkers (adenine, glucose, hypo-
xanthine, lactate, malate, nicotinamide, 5-oxoproline, and xanthine) recapitulate the qualita-
tive trend of the entire metabolome. However, it has yet to be determined whether these
biomarkers can be used to predict quantitative network behavior.
In this study, we determine that five of the eight biomarkers (glucose, hypoxanthine, lactate,
malate, and xanthine) are not only excellent qualitative predictors, but also accurate quantita-
tive predictors of metabolic concentrations in the rest of the metabolic network. Using a simple
computational formulation [14] prevalent in a variety of fields [15–18], we extend the utility of
these biomarkers by using them to quantitatively predict the concentration profiles of 91 other
metabolites in the network. This added use of validated biomarkers offers the potential for a
powerful workflow that utilizes five biomarkers to evaluate the state of RBC metabolism.
Results
For this study, we used the metabolomics data set from Bordbar et al. [10] that measured 96
intracellular and extracellular metabolites in human red blood cells under storage conditions.
The data set measured 14 time points over a 45 day time period for 20 biological replicates. For
the purposes of modeling, we randomly divided these 20 replicates into equal sized training
and testing sets of 10 samples. We observed a high amount of variability in the extracellular
glucose measurement at Day 31 (S1 Fig), a behavior which was not observed in the intracellu-
lar glucose measurement (S2A Fig) but was seen in other extracellular measurements at Day
31 (S2B Fig). In order to avoid bias arising from the inclusion of potentially erroneous data, we
excluded the measurements from Day 31, resulting in 13 total time points spanning 45 days of
storage.
We trained multiple polynomial models of varying complexity on the concentration pro-
files of the biomarkers and the concentration profile of the target metabolite (Fig 1). The best
performing model was a simple, linear Output-Error model [14]. Variation between blood
bags is a known challenge, as both donor and technical factors contribute to sample heteroge-
neity [1]. Due to this variation, we noted that simply because these eight biomarkers are good
qualitative predictors of systemic behavior does not imply that they are also good quantitative
predictors. We therefore performed a feature selection and cross validation within the eight
biomarkers, determining that adenine, nicotinamide, and 5-oxoproline were not able to quan-
titatively predict systemic behavior as well as the other five biomarkers (see Methods). Thus,
glucose, hypoxanthine, lactate, malate, and xanthine were used for the remaining analysis.
In order to generate a prediction for each metabolite, we trained the model using the five
biomarkers and a measured profile for the target metabolite as input (Fig 1). We used an
ensemble modeling approach [19] to reduce bias arising from using either individual replicates
or averaging replicates to train a single model. With 10 training replicates, this approach
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allowed us to generate an ensemble of trained models that inherently includes the biological
variation of the training data (S3 Fig). We then used this trained ensemble computational
model to predict a consensus concentration profile of a target metabolite, this time only using
the biomarkers as input (Fig 1).
We tested the model’s capabilities by comparing the predicted profiles of the remaining 91
measured metabolites to their measured profiles (Fig 2). We calculated the symmetric mean
absolute percentage error (SMAPE) for each predicted concentration profile, resulting in a
median error of 0.1340 ± 0.1505 (S4 Fig). See Supplementary Material for all predicted profiles.
To further validate our model, we compared against 10,000 profiles generated using a naive
random walk for each metabolite. The naive random walk model assumes that metabolite con-
centration changes over time are independent of each other and are normally distributed. The
random walk is a widely used benchmark for dynamic forecasting models [20]. When a signifi-
cant number (500/10,000, i.e.,5%) of random walks outperform a trained model for a
metabolite, we conclude that the dynamics of that metabolite are indiscernible from noise for
the data given (see Methods for details on the random walk comparison). Despite the complex-
ity of RBC metabolism, we found that 84/91 (92%) of RBC metabolites were predicted more
accurately than random walks using five biomarkers as input (p< 0.05).
In an effort to lend biological intuition to this surprising result, we viewed these results in
the context of the complete RBC metabolic network (Fig 2, S5 Fig). The map highlights several
points. First, the five biomarkers are largely distributed across key subsystems. Surprisingly,
two biomarkers are adjacent in the network: xanthine and hypoxanthine. From inspection of
the map, it becomes more intuitive that to unambiguously predict IMP levels (Fig 2), both bio-
markers need to be quantitatively measured.
Discussion
RBCs in storage undergo a series of morphological changes (commonly referred to as “storage
lesion”) that become more pronounced throughout the storage process [1, 21, 22]. Recent
Fig 1. Prediction workflow. A: The model is trained on the measured concentration profiles of the five
biomarkers (glucose, hypoxanthine, lactate, malate, and xanthine) and the target metabolite. B: The resulting
ensemble of models (one for each replicate) can then be used to predict the concentration profile of the target
metabolite given only the measured concentration profiles of the five biomarkers.
doi:10.1371/journal.pcbi.1005424.g001
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studies have shown that blood transfused after being stored for longer than five weeks is associ-
ated with post-transfusion complications [23, 24], indicating the serious clinical implications
of metabolic decay in transfused blood. With the recent identification of eight extracellular
biomarkers that are able to define this decay, the field of transfusion medicine now has an
opportunity to define the metabolic state of stored RBCs with just a few measurements. Thus,
there is a need for predictive modeling methods that can extend the applicability of these bio-
markers to provide deeper understanding of the metabolic state of RBCs collected and stored
under blood banking conditions using current and future technologies (e.g., improved bags or
storage solutions, pathogen reduction technologies).
Fig 2. Predicted concentration profiles. Using the five biomarkers (highlighted in red), the concentration profiles for the remaining 91 measured
metabolites were predicted (inset profile metabolites are highlighted in yellow). The remaining 81 predicted profiles are provided in the Supplementary
Material. See S5 Fig for full map detail.
doi:10.1371/journal.pcbi.1005424.g002
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In this study, we have developed a statistical model that uses these biomarkers to predict the
time series concentration profiles of other metabolites in the RBC metabolic network. This
powerful tool was rigorously validated to avoid overfitting through model (complexity) and
feature selection, and comparing against a standard forecasting baseline model (i.e., naive ran-
dom walk). As with any data modeling approach, the performance of a model is dependent
upon the quality of the input data; this is no exception here. We see that certain metabolites
(e.g., ADP, inosine) had higher prediction errors, which can be partially attributed to noise in
the training data and to low concentrations (S6 Fig).
The results presented here have two important implications. First, we have shown that if
good biomarkers are available for a given system (like for the human RBC), then they can be
used to make quantitative predictions about systemic behavior. Second, this provides the
potential for a cost-effective workflow to monitor the metabolic state of a biological system
since the only input under new conditions is the concentration profiles of biomarkers.
Through the use of modeling and statistical analysis, the measured and predicted concentra-
tions would enable a quantitative understanding of systems-level behavior.
Thus, we have demonstrated the predictive power of biomarkers through the use of a statis-
tical model for RBCs in storage. This data-driven statistical modeling approach performed
remarkably well for the RBC system, even without a detailed kinetic model. These results are
encouraging and provide a complementary approach for predicting metabolite dynamics in
less characterized organisms. As our validation procedure indicates, a critical mass of high-
quality data is required to extract meaningful signals from noise. Our workflow provides a
valuable assessment on whether this critical mass has been satisfied; the results here indicate
that as few as 20 biological replicates are sufficient to provide a training set capable of achieving
>90% accuracy. Follow up studies should address the question of how many measurements
need to be made during storage in order to provide a reliable assessment of the RBC metabo-
lome during storage, as this question has direct clinical implications.
As biomarkers are identified for new systems, there will be a need to analyze omics in an
attempt to efficiently characterize complex biological systems using just these few informative
measurements. Our workflow addresses this need by incorporating such biomarkers with a
statistical model, offering broad utility in both the laboratory and the clinic.
Methods
All computations were performed in Matlab R2016b (Mathworks, Natick, MA).
System identification
An Output Error (OE) model [14] predicts system dynamics from past values, measured
inputs, and unmeasured disturbances as follows:
yðtÞ ¼
Xn
i¼1
BiðqÞ
FiðqÞ
uiðt   nkiÞ þ eðtÞ ð1Þ
where y(t) is the output at time t, ui is an input (i.e., metabolite i), e is the unmeasured distur-
bance (i.e., system noise), and B(q) and F(q) are polynomials expressed in the time-shift opera-
tor q as follows:
BðqÞ ¼ b1 þ b2q
  1 þ . . .þ bnbq
  nbþ1 ð2Þ
FðqÞ ¼ 1þ f1q
  1 þ . . .þ fnf q
  nf : ð3Þ
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For this system, n = 5 (i.e., the five biomarkers), nb = 1, nf = 0, and there was no input delay
(nk = 0). The B and F polynomials are estimated during the system identification step using
least squares regression to minimize the difference between the measured signal and the pre-
dicted output.
This OE model performed better than more complex OE models having higher nb and
more complex polynomial models. It also performed better than simpler linear regression—
the OE model thus represents an optimal degree of complexity.
Model evaluation
In order to evaluate the accuracy of the predicted concentration profiles for the various metab-
olites, we calculated the symmetric mean absolute percentage error (SMAPE), given by:
SMAPE ¼
1
n
Xn
t¼1
jyt   y^ tj
yt þ y^ t
ð4Þ
where n is the number of time points, y is the measured concentration profile, and y^ is the pre-
dicted concentration profile. For the global statistics reported in S4 Fig, the mean of the
SMAPE of the 10 predicted profiles is given.
Quantitative biomarker selection
We trained the OE model using a recently published metabolomics data set of RBCs under
storage conditions at 4˚C with 20 biological replicates from Bordbar et al. [10]. In order to pre-
dict the concentration of target metabolites, we used the eight extracellular biomarkers [6] as
input since they are highly representative of the qualitative behavior of the rest of the system.
In order to determine if these biomarkers are also good quantitative predictors, we performed
a 10-fold cross validation on the set of 10 samples used for training the model to verify the gen-
eralization performance of the trained model. We ran our cross validation on all 56 combina-
tions of five biomarkers (i.e., 8 choose 5); the five selected biomarkers had a mean SMAPE of
10.33%, which was within 1% of the top performing set of five biomarkers. Thus, we used glu-
cose, hypoxanthine, lactate, malate, and xanthine as the final set of biomarkers input to the OE
model.
Training an ensemble of models
We trained an ensemble of OE models using the five biomarker profiles and each of the 91
measured metabolite profiles. Thus, we trained 91 ensemble models (one ensemble for each
metabolite). Each ensemble model consisted of 10 OE models, each trained on a biological rep-
licate. We used Bags 1–10 as this training set. We combined the outputs of these 10 OE models
into a single prediction for each metabolite by computing the median of the 10 predictions at
each time point (S3 Fig). This ensemble modeling approach captures the biological variability
inherent among the samples used for training.
Predictions on testing data
We used Bags 11–20 as the testing data set. In order to assess the variability between the train-
ing and testing data, we performed a two-sample t-test at each time point for each metabolite.
This showed that approximately 24% of the data rejected the null hypothesis (FDR-adjusted
p< 0.05) that the two data sets came from the same distribution and also showed greater than
a 20% difference in the mean concentrations at a given time point (S7 Fig). For each test repli-
cate, the five biomarkers were input to the trained ensemble model.
Biomarkers predict metabolite concentration profiles
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Comparison to naive random walk
In addition to the prediction error, as computed by SMAPE, we also evaluated our model by
comparing its performance against a benchmark model. We chose as a benchmark the random
walk model, which assumes that metabolite concentration changes over time are independent
of each other and are normally distributed with zero mean. The random walk model is com-
monly used to benchmark dynamic forecasting models [20]. To ensure that the random walk
was representative of the metabolite concentration changes, we estimated the standard devia-
tion of random changes from all 10 testing replicates across all time points for each metabolite.
We further ensured that the random walk was an appropriate benchmark by initializing with a
realistic concentration. To do so, we randomly chose from the pool of the 10 measured starting
points of the testing replicates for each metabolite.
We generated 10,000 of these random walk profiles for each metabolite. In order to compare
these to our model predictions, our null hypothesis was that our trained model performed no
better than the random profiles. We calculated the SMAPE for each of the random profiles and
compared to the SMAPE for the predicted profiles; the given p value is the number of random
profiles which had a lower SMAPE than the average of the predicted profiles for that metabolite.
Supporting information
S1 Fig. Biomarker profiles. The concentration profiles for the biomarkers are shown for the
full 45 day time course with all 14 time points included.
(PDF)
S2 Fig. Metabolites whose behavior at Day 31 indicates that the time point should be
removed. A: The concentration profile for intracellular glucose does not show an increase at
Day 31 that corresponds with the spike observed in extracellular glucose (S1 Fig). B: The con-
centration profiles of extracellular chloride and sodium show the same abnormal behavior as
extracellular glucose at Day 31.
(PDF)
S3 Fig. Example of individual replicate predictions. Each subplot represents one testing rep-
licate of the 10 shown in Fig 2. The red swathe represents the spread of the predictions of each
of the 10 trained models included in the ensemble model. The red dashed line is the median of
the 10 trained models and the final output for each replicate. The black points represent the
measured testing data.
(PDF)
S4 Fig. Global statistics for all predicted metabolites. We calculated the mean of the sym-
metric mean absolute percentage error (SMAPE) for the 10 predicted concentration profiles
for each metabolite.
(PDF)
S5 Fig. Full map for the RBC metabolic network.
(PDF)
S6 Fig. Metabolites with poor model predictions. The metabolites shown are those for which
the model predictions were not significantly better (p> 0.05) than the naive random walk.
The distribution of SMAPEs for all ten predictions are shown on the right.
(PDF)
S7 Fig. Statistical analysis between training and testing data sets. The color bar represents
the percent difference between the means concentrations for each metabolite at each time point
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between the training and testing data sets. An “X” indicates that the distributions of the training
and testing data were significantly different (two-sample t-test, FDR-adjusted p< 0.05).
(PDF)
S8 Fig. Measured data and predicted profiles. The distribution of SMAPEs for all ten predic-
tions are shown on the right. Abbreviations are BiGG metabolite IDs.
(PDF)
S9 Fig. Measured data and predicted profiles. The distribution of SMAPEs for all ten predic-
tions are shown on the right. Abbreviations are BiGG metabolite IDs.
(PDF)
S10 Fig. Measured data and predicted profiles. The distribution of SMAPEs for all ten pre-
dictions are shown on the right. Abbreviations are BiGG metabolite IDs.
(PDF)
S11 Fig. Measured data and predicted profiles. The distribution of SMAPEs for all ten pre-
dictions are shown on the right. Abbreviations are BiGG metabolite IDs.
(PDF)
S12 Fig. Measured data and predicted profiles. The distribution of SMAPEs for all ten pre-
dictions are shown on the right. Abbreviations are BiGG metabolite IDs.
(PDF)
S13 Fig. Measured data and predicted profiles. The distribution of SMAPEs for all ten pre-
dictions are shown on the right. Abbreviations are BiGG metabolite IDs.
(PDF)
S14 Fig. Measured data and predicted profiles. The distribution of SMAPEs for all ten pre-
dictions are shown on the right. Abbreviations are BiGG metabolite IDs.
(PDF)
S15 Fig. Measured data and predicted profiles. The distribution of SMAPEs for all ten pre-
dictions are shown on the right. Abbreviations are BiGG metabolite IDs.
(PDF)
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